1 |
Amoxapine & dipyridamole |
Amoxapine |
2件: D00228 D00228, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, SLC6A2, SLC6A4 💬 |
Metabolic pathways 8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
2 |
Dipyridamole |
Dipyridamole |
1件: D00302 D00302 💬 |
PDE4A 2件: PDE4A, PDE5A 💬 |
Metabolic pathways 6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 5件: 46, 49, 51, 66, 224 💬 |
3 |
Dipyridamole and amoxapine |
Amoxapine |
2件: D00228 D00228, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, SLC6A2, SLC6A4 💬 |
Metabolic pathways 8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
4 |
Dipyridamole tab 25 mg |
Dipyridamole |
1件: D00302 D00302 💬 |
PDE4A 2件: PDE4A, PDE5A 💬 |
Metabolic pathways 6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
224 1件: 224 💬 |
5 |
Extended release dipyridamole 200mg/aspirin 25mg |
Acetylsalicylic acid |
2件: D00109 D00109, D00302 D00302 💬 |
PDE4A 4件: PDE4A, PDE5A, PTGS1, PTGS2 💬 |
Alzheimer disease 28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway |
049 1件: 49 💬 |
6 |
Persantin |
- |
- |
- |
- |
046 1件: 46 💬 |
7 |
Persantin 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
8 |
Persantin 100 mg and |
- |
- |
- |
- |
046 1件: 46 💬 |
9 |
Prednisolone & dipyridamole |
Dipyridamole |
9件: D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 3件: NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
10 |
Prednisolone-dipyridamole |
Dipyridamole |
9件: D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 3件: NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |
11 |
Z102 (prednisolone and dipyridamole). |
Dipyridamole |
9件: D00302 D00302, D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 3件: NR3C1, PDE4A, PDE5A 💬 |
Metabolic pathways 7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 1件: 46 💬 |